| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.06 |